<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6821420</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btz289</article-id>
    <article-id pub-id-type="publisher-id">btz289</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>INDRA-IPM: interactive pathway modeling using natural language with automated assembly</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Todorov</surname>
          <given-names>Petar V</given-names>
        </name>
        <xref ref-type="author-notes" rid="btz289-FM1"/>
        <xref ref-type="aff" rid="btz289-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gyori</surname>
          <given-names>Benjamin M</given-names>
        </name>
        <xref ref-type="author-notes" rid="btz289-FM1"/>
        <xref ref-type="aff" rid="btz289-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6095-2466</contrib-id>
        <name>
          <surname>Bachman</surname>
          <given-names>John A</given-names>
        </name>
        <xref ref-type="aff" rid="btz289-aff1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sorger</surname>
          <given-names>Peter K</given-names>
        </name>
        <xref ref-type="corresp" rid="btz289-cor1"/>
        <!--<email>peter_sorger@hms.harvard.edu</email>-->
        <xref ref-type="aff" rid="btz289-aff1"/>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Kelso</surname>
          <given-names>Janet</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="btz289-aff1"><institution>Laboratory of Systems Pharmacology, Harvard Medical School</institution>, Boston, MA, USA</aff>
    <author-notes>
      <fn id="btz289-FM1">
        <p>The authors wish it to be known that, in their opinion, Petar V. Todorov and Benjamin M. Gyori authors should be regarded as Joint First Authors.</p>
      </fn>
      <corresp id="btz289-cor1">To whom correspondence should be addressed. E-mail: <email>peter_sorger@hms.harvard.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>11</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2019-05-09">
      <day>09</day>
      <month>5</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>09</day>
      <month>5</month>
      <year>2019</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>35</volume>
    <issue>21</issue>
    <fpage>4501</fpage>
    <lpage>4503</lpage>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>8</month>
        <year>2018</year>
      </date>
      <date date-type="rev-recd">
        <day>04</day>
        <month>4</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>4</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2019. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btz289.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>INDRA-IPM (Interactive Pathway Map) is a web-based pathway map modeling tool that combines natural language processing with automated model assembly and visualization. INDRA-IPM contextualizes models with expression data and exports them to standard formats.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>INDRA-IPM is available at: <ext-link ext-link-type="uri" xlink:href="http://pathwaymap.indra.bio">http://pathwaymap.indra.bio</ext-link>. Source code is available at <ext-link ext-link-type="uri" xlink:href="http://github.com/sorgerlab/indra_pathway_map">http://github.com/sorgerlab/indra_pathway_map</ext-link>. The underlying web service API is available at <ext-link ext-link-type="uri" xlink:href="http://api.indra.bio:8000">http://api.indra.bio:8000</ext-link>.</p>
      </sec>
      <sec id="s3">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">DARPA Big Mechanism</named-content>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">CwC Programs</named-content>
        </funding-source>
        <award-id>W911NF-14-1-0397</award-id>
        <award-id>W911NF-15-1-0544</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">NIH</named-content>
          <named-content content-type="funder-identifier">10.13039/100000002</named-content>
        </funding-source>
        <award-id>P50-GM107618</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Disease or process-specific pathway maps are commonly used to communicate mechanistic information about interacting genes and proteins (<xref rid="btz289-B9" ref-type="bibr">Ostaszewski <italic>et al.</italic>, 2018</xref>). These maps contain information on biomolecules and their interactions organized around a specific biological process, for instance growth-factor signaling mediated by RAS and MAP kinases (<xref rid="btz289-B12" ref-type="bibr">Stephen <italic>et al.</italic>, 2014</xref>). Unlike genome-wide interactomes, pathway maps are typically restricted in scope and are fit to purpose to improve human intelligibility and avoid the ‘hairball effect’.</p>
    <p>Multiple graphical editing tools have been developed to assemble and display pathway maps (<xref rid="btz289-B7" ref-type="bibr">King <italic>et al.</italic>, 2015</xref>; <xref rid="btz289-B8" ref-type="bibr">O’Hara <italic>et al.</italic>, 2016</xref>; <xref rid="btz289-B11" ref-type="bibr">Sari <italic>et al.</italic>, 2015</xref>) but these do not currently use the primary medium of scientific communication in biomedicine: natural language. Natural language descriptions are familiar, do not require specialized expertise to create and edit, and can be drawn directly from the scientific literature (<xref rid="btz289-B6" ref-type="bibr">Gyori <italic>et al.</italic>, 2017</xref>). The use of natural language interfaces for pathway modeling and analysis makes it possible to draw on a much larger community of experts.</p>
    <p>In this article, we describe the INDRA (Integrated Network and Dynamical Reasoning Assembler) Interactive Pathway Map (INDRA-IPM), a web-based pathway modeling tool that builds on the capabilities of INDRA (<xref rid="btz289-B6" ref-type="bibr">Gyori <italic>et al.</italic>, 2017</xref>) to construct and edit pathway maps in natural language and display the results in familiar graphical formats. INDRA-IPM allows models to be exported in several different standard exchange formats, thereby enabling the use of existing tools for causal inference, visualization and kinetic modeling. We also make the capabilities of IPM available as a web service to facilitate use by other software.</p>
  </sec>
  <sec>
    <title>2 Results</title>
    <sec>
      <title>2.1 Pathway map construction</title>
      <p>INDRA-IPM provides an interface to enter English language text describing mechanisms used to generate a pathway map. This description is processed by one or more natural language processing (NLP) systems; users can choose between the REACH (<xref rid="btz289-B13" ref-type="bibr">Valenzuela-Escarcega <italic>et al.</italic>, 2017</xref>) and TRIPS (<xref rid="btz289-B1" ref-type="bibr">Allen <italic>et al.</italic>, 2015</xref>) NLP systems. A pathway map is then generated automatically from the NLP output and visualized dynamically. Users can iteratively update and extend the pathway map by editing the underlying natural language.</p>
    </sec>
    <sec>
      <title>2.2 Visual representation</title>
      <p>The pathway map is represented as a directed graph with nodes corresponding to molecular entities (genes/proteins, families, complexes and small molecules) and edges representing mechanistic relationships among them. The graph is displayed using CytoscapeJS (<xref rid="btz289-B5" ref-type="bibr">Franz <italic>et al.</italic>, 2015</xref>) with a two-stage hierarchical layout procedure designed to reduce visual complexity. INDRA-IPM groups nodes with identical incoming and outgoing edges and aggregates them into a single bounding box with collapsed edges (e.g. RASGRF and SOS in <xref ref-type="fig" rid="btz289-F1">Fig. 1</xref>). Nodes representing protein families or complexes (e.g. the Sprouty family, SPRY in <xref ref-type="fig" rid="btz289-F1">Fig. 1</xref>), are recognized using the FamPlex ontology (<xref rid="btz289-B2" ref-type="bibr">Bachman <italic>et al.</italic>, 2018</xref>) and represented by a single node subdivided to show the genes in the family as slices.
</p>
      <fig id="btz289-F1" orientation="portrait" position="float">
        <label>Fig. 1.</label>
        <caption>
          <p>Pathway maps are assembled from natural language descriptions of mechanisms (1). INDRA-IPM renders pathway maps as graphs with node and edge grouping and coloring determined by mutational status and expression level (2). Pathways can be stored and shared on NDEx and exported and downloaded in many standard formats (3). Node tooltips provide links to online databases having information on genes/protein in the pathway and also to antibodies against proteins in the node (4). Literature-based evidence for a given interaction can be accessed by clicking on an edge. Corresponding evidence sentences drawn from these publications are then shown with links out to the PubMed entry in which the sentences are found (5)</p>
        </caption>
        <graphic xlink:href="btz289f1"/>
      </fig>
    </sec>
    <sec>
      <title>2.3 Integration with modeling and exchange formats</title>
      <p>To leverage automated assembly for diverse modeling tasks, INDRA-IPM exports models as SBML, SBGN, BNGL, Kappa, PySB and CX. These formats are widely used in computational biology for modeling, simulating and visualizing pathways. Users also have the option of storing maps on the Network Data Exchange (NDEx) (<xref rid="btz289-B10" ref-type="bibr">Pratt <italic>et al.</italic>, 2015</xref>) where they can be shared and reloaded into INDRA-IPM using a persistent URL. More details on these formats are available in the <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>.</p>
    </sec>
    <sec>
      <title>2.4 Integration with gene level data</title>
      <p>INDRA-IPM enables users to project mutation and expression data onto the pathway map and thereby visualize data specific to a particular cell type. Mutation status is mapped to color (with green nodes denoting wild-type and orange nodes mutations) and relative expression levels to color intensity (greater color saturation denotes higher expression). Cancer Cell Line Encyclopedia (CCLE; <xref rid="btz289-B3" ref-type="bibr">Barretina <italic>et al.</italic>, 2012</xref>) data are embedded in INDRA-IPM making it possible to view mutation and expression information for 996 cell lines.</p>
    </sec>
    <sec>
      <title>2.5 Integration with external resources</title>
      <p>The NLP tools used by INDRA-IPM link each node (or subnode in a family) to a database identifier using named entity recognition. This makes it possible to connect a pathway map to standard external resources via uniform identifiers. For example, by clicking on a node, a tooltip appears with links to HGNC, UniProt and CiteAb, allowing users to access details about the constituents of a pathway and identify reagents useful for experiments (e.g. antibodies).</p>
    </sec>
    <sec>
      <title>2.6 Integration with evidence from scientific literature</title>
      <p>Clicking on an edge in a pathway map retrieves support for that interaction by querying a database of interactions aggregated by INDRA. This database includes information gathered from reading literature at scale (<xref rid="btz289-B13" ref-type="bibr">Valenzuela-Escarcega <italic>et al.</italic>, 2017</xref>) and information found in curated knowledge bases such as Pathway Commons (<xref rid="btz289-B4" ref-type="bibr">Cerami <italic>et al.</italic>, 2011</xref>) and the BEL Large Corpus (<ext-link ext-link-type="uri" xlink:href="http://www.openbel.org">www.openbel.org</ext-link>). Users are therefore able to access literature support for relationships specified in natural language descriptions.</p>
    </sec>
    <sec>
      <title>2.7 RAS pathway map</title>
      <p>As a demonstration of INDRA-IPM, we wrote 43 English sentences to capture all nodes and interactions in a pathway map originally created by the NCI RAS Initiative (cancer.gov/research/key-initiatives/ras). The INDRA-IPM map automatically follows the same visual conventions as the hand-drawn map, hierarchically organizing the graph and spatially grouping related nodes to reduce clutter. In addition, INDRA-IPM substantially extends the original map by providing access to supporting evidence sourced by INDRA, linking elements to external data resources and provide context from CCLE data. The RAS pathway map is available as a built-in example in INDRA-IPM.</p>
    </sec>
    <sec>
      <title>2.8 Web service API</title>
      <p>To facilitate integration of INDRA-IPM with other tools, we make it available a Web-based API that accesses reading, assembly and export functions of INDRA-IPM. </p>
    </sec>
  </sec>
  <sec>
    <title>Funding</title>
    <p>This work was funded under the DARPA Big Mechanism and CwC Programs [W911NF-14-1-0397 and W911NF-15-1-0544] and by NIH [P50-GM107618].</p>
    <p><italic>Conflict of Interest</italic>: P.K.S. holds equity in Merrimack Pharmaceuticals, Glencoe Software, Applied Biomath and RareCyte Inc. P.K.S. declares that none of these relationships are directly or indirectly related to the content of this article.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>btz289_Supplementary_Data</label>
      <media xlink:href="btz289_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btz289-B1">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>J.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>Complex Event Extraction using DRUM</article-title>. In: Cohen,B.K. <etal>et al</etal> (eds) <source>Proceedings of BioNLP</source> 15, pp. <fpage>1</fpage>–<lpage>11</lpage>, 
<publisher-name>Association for Computational Linguistics</publisher-name>, 
<publisher-loc>Beijing</publisher-loc>.</mixed-citation>
    </ref>
    <ref id="btz289-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bachman</surname><given-names>J.A.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>FamPlex: a resource for entity recognition and relationship resolution of human protein families and complexes in biomedical text mining</article-title>. <source>BMC Bioinformatics</source>, <volume>19</volume>, <fpage>248</fpage>.<pub-id pub-id-type="pmid">29954318</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barretina</surname><given-names>J.</given-names></name></person-group><etal>et al</etal> (<year>2012</year>) 
<article-title>The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity</article-title>. <source>Nature</source>, <volume>483</volume>, <fpage>603</fpage>–<lpage>607</lpage>.<pub-id pub-id-type="pmid">22460905</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cerami</surname><given-names>E.G.</given-names></name></person-group><etal>et al</etal> (<year>2011</year>) 
<article-title>Pathway Commons, a web resource for biological pathway data</article-title>. <source>Nucleic Acids Res</source>., <volume>39</volume>, <fpage>D685</fpage>–<lpage>D690</lpage>.<pub-id pub-id-type="pmid">21071392</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Franz</surname><given-names>M.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>Cytoscape.js: a graph theory library for visualisation and analysis</article-title>. <source>Bioinformatics</source>, <volume>32</volume>, <fpage>btv557</fpage>.</mixed-citation>
    </ref>
    <ref id="btz289-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gyori</surname><given-names>B.M.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>From word models to executable models of signaling networks using automated assembly</article-title>. <source>Mol. Syst. Biol</source>., <volume>13</volume>, <fpage>954</fpage>.<pub-id pub-id-type="pmid">29175850</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>Z.A.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>Escher: a web application for building, sharing, and embedding data-rich visualizations of biological pathways</article-title>. <source>PLoS Comput. Biol</source>., <volume>11</volume>, <fpage>e1004321.</fpage><pub-id pub-id-type="pmid">26313928</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Hara</surname><given-names>L.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Modelling the structure and dynamics of biological pathways</article-title>. <source>PLoS Biol</source>., <volume>14</volume>, <fpage>e1002530.</fpage><pub-id pub-id-type="pmid">27509052</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ostaszewski</surname><given-names>M.</given-names></name></person-group><etal>et al</etal> (<year>2018</year>) 
<article-title>Community-driven roadmap for integrated disease maps</article-title>. <source>Brief. Bioinform</source>., <fpage>bby024</fpage>.</mixed-citation>
    </ref>
    <ref id="btz289-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pratt</surname><given-names>D.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>NDEx, the Network Data Exchange</article-title>. <source>Cell Syst</source>., <volume>1</volume>, <fpage>302</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">26594663</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sari</surname><given-names>M.</given-names></name></person-group><etal>et al</etal> (<year>2015</year>) 
<article-title>SBGNViz: a tool for visualization and complexity management of SBGN process description maps</article-title>. <source>PLoS One</source>, <volume>10</volume>, <fpage>e0128985.</fpage><pub-id pub-id-type="pmid">26030594</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stephen</surname><given-names>A.G.</given-names></name></person-group><etal>et al</etal> (<year>2014</year>) 
<article-title>Dragging ras back in the ring</article-title>. <source>Cancer Cell</source>, <volume>25</volume>, <fpage>272</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">24651010</pub-id></mixed-citation>
    </ref>
    <ref id="btz289-B13">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Valenzuela-Escarcega</surname><given-names>M.A.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) Large-scale automated reading with Reach discovers new cancer driving mechanisms. In: <italic>Proceedings of the Sixth BioCreative Challenge Evaluation Workshop</italic>, pp. <fpage>201</fpage>–<lpage>203</lpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
